Cargando…
Effectors of the Type VI Secretion System Have the Potential to Be Modified into Antimicrobial Peptides
The use of antibiotics has led to the emergence of multidrug-resistant (MDR) bacteria, and there is an urgent need to find alternative treatments to alleviate this pressure. The type VI secretion system (T6SS) is a protein delivery system present in bacterial cells that secretes effectors that parti...
Autores principales: | Lu, Wenjia, Lu, Hao, Wang, Chenchen, Wang, Gaoyan, Dong, Wenqi, Tan, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434152/ https://www.ncbi.nlm.nih.gov/pubmed/37470717 http://dx.doi.org/10.1128/spectrum.00308-23 |
Ejemplares similares
-
Repurposing Ellipticine Hydrochloride to Combat Colistin-Resistant Extraintestinal Pathogenic E. coli (ExPEC)
por: Lu, Hao, et al.
Publicado: (2020) -
Apigenin and Ampicillin as Combined Strategy to Treat Severe Streptococcus suis Infection
por: Lu, Hao, et al.
Publicado: (2021) -
Activity of Oritavancin and Its Synergy with Other Antibiotics against Mycobacterium abscessus Infection In Vitro and In Vivo
por: Wang, Gaoyan, et al.
Publicado: (2021) -
Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe Streptococcus suis Infections
por: Lu, Hao, et al.
Publicado: (2020) -
Type VI Secretion Effectors: Methodologies and Biology
por: Lien, Yun-Wei, et al.
Publicado: (2017)